TrialInfection and immunity2005

Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial.

Giane A Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.